Skip to main content
. 2016 Oct 12;7(50):82266–82272. doi: 10.18632/oncotarget.12619

Table 2. Association statistics between relative Gal-3 and relative PSA levels.

Group rho P-value Slope 90% CI P-value
All men 0.446 < 0.0001* 0.448 (0.302, 0.593) < 0.0001*
Healthy controls 0.347 0.1451 0.347 (0.031, 0.664) 0.0734
Newly diagnosed 0.616 0.0050* 0.438 (0.244, 0.633) 0.0011*
No recurrence 0.484 0.0360* 0.470 (0.156, 0.785) 0.0187*
Rising PSA 0.202 0.4075 0.162 (-0.048, 0.372) 0.1967
Metastasis 0.395 0.0944 0.368 (-0.074, 0.810) 0.1661

Gal-3 and PSA concentrations were divided by their respective autoantibody levels, and the values were referred to as relative Gal-3 and relative PSA. The table shows Spearman rank correlation coefficients (rho values) and their P-values (left) between relative Gal-3 and relative PSA level for each clinical group. The fitted slope, its 90% confidence interval (CI), and P-value are also shown for the linear regression model of relative PSA and relative Gal-3 (right). A P-value of less than 0.05 was considered statistically significant and shown with asterisks (*).